<DOC>
	<DOC>NCT00141414</DOC>
	<brief_summary>To evaluate the long-term safety of pregabalin in refractory partial epilepsy.</brief_summary>
	<brief_title>To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies, Partial</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Must have met the inclusion criteria for preceding doubleblind study. Have received doubleblind study medication and wish to receive openlabel pregabalin. Pregnant or considering becoming pregnant. Receiving any concomitant medication that could alter the effectiveness of their medication response or seizure frequency.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2006</verification_date>
</DOC>